Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143684 |
| CAS No | NA |
| Mol.F. | C22H29N3O6 |
| Mol.Wt. | 431.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143685 |
| CAS No | NA |
| Mol.F. | C24H33N3O6 |
| Mol.Wt. | 459.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143686 |
| CAS No | NA |
| Mol.F. | C23H31N3O6 |
| Mol.Wt. | 445.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143687 |
| CAS No | NA |
| Mol.F. | C23H31N3O6 |
| Mol.Wt. | 445.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143688 |
| CAS No | NA |
| Mol.F. | C23H31N3O6 |
| Mol.Wt. | 445.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143689 |
| CAS No | NA |
| Mol.F. | C23H31N3O6 |
| Mol.Wt. | 445.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143690 |
| CAS No | NA |
| Mol.F. | C15H18N2O3 : HCl |
| Mol.Wt. | 274.3 : 36.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143691 |
| CAS No | NA |
| Mol.F. | C12H13N3O4 |
| Mol.Wt. | 263.25 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143692 |
| CAS No | NA |
| Mol.F. | C7H9N5O |
| Mol.Wt. | 179.2 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143693 |
| CAS No | NA |
| Mol.F. | C19H15D4ClN4O7S |
| Mol.Wt. | 486.9 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143694 |
| CAS No | NA |
| Mol.F. | C21H26N4O3 |
| Mol.Wt. | 382.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143695 |
| CAS No | NA |
| Mol.F. | C12H9D3N2O |
| Mol.Wt. | 203.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143696 |
| CAS No | NA |
| Mol.F. | C15H23N5O3 |
| Mol.Wt. | 321.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143697 |
| CAS No | NA |
| Mol.F. | C10H15N5O |
| Mol.Wt. | 221.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143698 |
| CAS No | NA |
| Mol.F. | C10H15N5O |
| Mol.Wt. | 221.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143699 |
| CAS No | NA |
| Mol.F. | C10H14N6O2 |
| Mol.Wt. | 250.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |